Stay updated on Oral Difelikefalin Adjunct in Atopic Dermatitis Clinical Trial
Sign up to get notified when there's something new on the Oral Difelikefalin Adjunct in Atopic Dermatitis Clinical Trial page.

Latest updates to the Oral Difelikefalin Adjunct in Atopic Dermatitis Clinical Trial page
- Check5 days agoChange DetectedThe ClinicalTrials.gov record for the difelikefalin study is now displayed, including its design, eligibility criteria, locations, and study dates. It reports that the study was terminated after Part A showed no meaningful clinical benefit over topical corticosteroids alone.SummaryDifference78%

- Check12 days agoChange DetectedThe footer revision label changed from v3.7.2 to v3.8.0 while the study page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check19 days agoChange DetectedA site-wide banner announces updates and FAQs about NIH’s transition from the term “Artificial Intelligence” to “Super Intelligence.”SummaryDifference1%

- Check26 days agoChange DetectedThe site revision label in the footer updates from v3.7.1 to v3.7.2. The page still displays a 403 Forbidden error instead of the study record.SummaryDifference0.2%

- Check33 days agoChange DetectedThe footer revision label changes from v3.7.0 to v3.7.1, while the 403 error content remains unchanged.SummaryDifference0.2%

- Check53 days agoChange DetectedA 403 Forbidden page now appears, replacing the usual study details with an access-restricted error message. This reflects a permissions issue rather than an update to study data.SummaryDifference18%

Stay in the know with updates to Oral Difelikefalin Adjunct in Atopic Dermatitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Oral Difelikefalin Adjunct in Atopic Dermatitis Clinical Trial page.